A team of researchers from the Southampton Biomedical Research Centre, led by Professor Chris Edwards, has conducted studies on dementia which are likely to radically change the approach to treatment research in this field. The team has analyzed data from 5,800 people, 3,876 of whom have regularly taken drugs for rheumatoid arthritis (DMARDs). The results demonstrate that the risk for people who assume anti-inflammatory drugs to develop Alzheimer’s or other forms of dementia halves. These results have proven so encouraging that Professor Edwards, his colleague Professor Clive Holmes and Dr Bernadette McGuinness (Belfast University) have received GBP400,000 funding by the Alzheimer Society in order to follow their research.
(Source NHS UK)